Concentrix Corporation (CNXC)
NASDAQ: CNXC · Real-Time Price · USD
54.87
+0.14 (0.26%)
At close: Jun 3, 2025, 4:00 PM
54.21
-0.66 (-1.20%)
After-hours: Jun 3, 2025, 5:19 PM EDT
Concentrix Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2017 - 2019 |
| Revenue | 9,588 | 9,619 | 7,115 | 6,324 | 5,587 | 4,720 | Upgrade
|
| Revenue Growth (YoY) | 21.66% | 35.20% | 12.50% | 13.20% | 18.38% | 0.25% | Upgrade
|
| Cost of Revenue | 6,140 | 6,170 | 4,537 | 4,067 | 3,618 | 3,058 | Upgrade
|
| Gross Profit | 3,448 | 3,449 | 2,578 | 2,257 | 1,969 | 1,662 | Upgrade
|
| Selling, General & Admin | 2,233 | 2,244 | 1,635 | 1,423 | 1,415 | 1,359 | Upgrade
|
| Operating Expenses | 2,692 | 2,703 | 1,850 | 1,586 | 1,415 | 1,359 | Upgrade
|
| Operating Income | 756.06 | 746.09 | 728.27 | 671.55 | 554.75 | 302.66 | Upgrade
|
| Interest Expense | -312.38 | -321.83 | -201 | -70.08 | -23.05 | -48.31 | Upgrade
|
| Currency Exchange Gain (Loss) | 16.98 | 9.94 | -13.01 | -57.98 | -2.88 | 32.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.19 | -7.43 | -4.39 | 95.28 | 14.5 | -18.6 | Upgrade
|
| EBT Excluding Unusual Items | 455.47 | 426.78 | 509.87 | 638.77 | 543.32 | 267.9 | Upgrade
|
| Merger & Restructuring Charges | -144.62 | -156.77 | -85.97 | -33.76 | -0.83 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 13.2 | - | Upgrade
|
| Other Unusual Items | 16.4 | 29.27 | -15.68 | - | - | - | Upgrade
|
| Pretax Income | 327.24 | 299.27 | 408.23 | 605 | 555.7 | 267.9 | Upgrade
|
| Income Tax Expense | 57.87 | 48.06 | 94.39 | 169.36 | 150.12 | 103.08 | Upgrade
|
| Earnings From Continuing Operations | 269.37 | 251.22 | 313.84 | 435.64 | 405.58 | 164.81 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -0.59 | - | - | Upgrade
|
| Net Income | 269.37 | 251.22 | 313.84 | 435.05 | 405.58 | 164.81 | Upgrade
|
| Preferred Dividends & Other Adjustments | 10.92 | 9.5 | 6 | 6.63 | 5.79 | - | Upgrade
|
| Net Income to Common | 258.45 | 241.71 | 307.84 | 428.42 | 399.79 | 164.81 | Upgrade
|
| Net Income Growth | -3.13% | -19.95% | -27.86% | 7.27% | 146.09% | 40.67% | Upgrade
|
| Shares Outstanding (Basic) | 65 | 65 | 54 | 51 | 51 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 65 | 54 | 52 | 52 | 52 | Upgrade
|
| Shares Change (YoY) | 12.25% | 20.48% | 4.39% | -0.34% | 0.60% | - | Upgrade
|
| EPS (Basic) | 4.00 | 3.72 | 5.72 | 8.34 | 7.78 | 3.19 | Upgrade
|
| EPS (Diluted) | 4.00 | 3.71 | 5.70 | 8.28 | 7.70 | 3.19 | Upgrade
|
| EPS Growth | -15.24% | -34.83% | -31.17% | 7.52% | 141.45% | 40.53% | Upgrade
|
| Free Cash Flow | 482.45 | 428.73 | 497.48 | 460.7 | 365.1 | 336.28 | Upgrade
|
| Free Cash Flow Per Share | 7.46 | 6.59 | 9.21 | 8.90 | 7.03 | 6.52 | Upgrade
|
| Dividend Per Share | 1.270 | 1.240 | 1.127 | 1.025 | 0.250 | - | Upgrade
|
| Dividend Growth | 10.00% | 10.00% | 10.00% | 310.00% | - | - | Upgrade
|
| Gross Margin | 35.96% | 35.85% | 36.23% | 35.69% | 35.25% | 35.20% | Upgrade
|
| Operating Margin | 7.89% | 7.76% | 10.24% | 10.62% | 9.93% | 6.41% | Upgrade
|
| Profit Margin | 2.70% | 2.51% | 4.33% | 6.77% | 7.16% | 3.49% | Upgrade
|
| Free Cash Flow Margin | 5.03% | 4.46% | 6.99% | 7.28% | 6.54% | 7.12% | Upgrade
|
| EBITDA | 1,439 | 1,452 | 1,117 | 981.09 | 831.92 | 579.22 | Upgrade
|
| EBITDA Margin | 15.00% | 15.10% | 15.69% | 15.51% | 14.89% | 12.27% | Upgrade
|
| D&A For EBITDA | 682.5 | 705.85 | 388.3 | 309.54 | 277.18 | 276.57 | Upgrade
|
| EBIT | 756.06 | 746.09 | 728.27 | 671.55 | 554.75 | 302.66 | Upgrade
|
| EBIT Margin | 7.89% | 7.76% | 10.24% | 10.62% | 9.93% | 6.41% | Upgrade
|
| Effective Tax Rate | 17.68% | 16.06% | 23.12% | 27.99% | 27.02% | 38.48% | Upgrade
|
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.